Tuesday, February 5, 2013

GSK announces support for AllTrials campaign for clinical data transparency

See the GSK press release here.  (Then wait to see what the company actually does.  As proof of good faith, GSK should officially retract Paxil Study 329.)

Update: Ed Silverman's take on the announcement at Pharmalot.

No comments:

Post a Comment